Persistent Glomerular Hematuria in Living Kidney Donors Confers a Risk of Progressive Kidney Disease in Donors After Heminephrectomy
Article first published online: 26 MAR 2010
DOI: 10.1111/j.1600-6143.2010.03077.x
©2010 The Authors Journal compilation©2010 The American Society of Transplantation and the American Society of Transplant Surgeons
Additional Information
How to Cite
Kido, R., Shibagaki, Y., Iwadoh, K., Nakajima, I., Fuchinoue, S., Fujita, T. and Teraoka, S. (2010), Persistent Glomerular Hematuria in Living Kidney Donors Confers a Risk of Progressive Kidney Disease in Donors After Heminephrectomy. American Journal of Transplantation, 10: 1597–1604. doi: 10.1111/j.1600-6143.2010.03077.x
Publication History
- Issue published online: 25 JUN 2010
- Article first published online: 26 MAR 2010
- Received 02 October 2009, revised 12 January 2010 and accepted for publication 01 February 2010
- Abstract
- Article
- References
- Cited By
Keywords:
- Donation;
- hematuria;
- kidney disease;
- kidney function;
- renal transplantation
Living kidney donors with persistent glomerular hematuria both pre- and post-donation had higher risk of developing persistent proteinuria or progressive decline in kidney function, suggesting the need for more discretion in selecting and following these donors. See editorial by Nankivell on page 1501.
Although glomerular hematuria is likely a sign of chronic kidney disease that will develop into overt nephropathy after donation, it remains unclear whether prospective donors with hematuria should be excluded. We reviewed the medical records of 242 donors who donated at our institution from 2001 to 2007 and surveyed the prevalence of hematuria pre- and postdonation. We then investigated the association of hematuria with proteinuria postdonation and trends in glomerular filtration rate. Before donation, 8.3% of 242 donors presented with persistent hematuria, a finding that was significantly associated with dysmorphic hematuria before donation. Most cases of predonation persistent hematuria persisted after donation, and the overall prevalence increased to 15.3%. During a median follow-up period of 2.3 years after donation, 8.3% developed persistent proteinuria, with incidence being significantly higher in donors having persistent hematuria with dysmorphic red blood cells (d-RBC) both before and after donation. Postdonation persistent hematuria with d-RBC was also associated with a progressive decline in renal function. These results indicate that persistent glomerular hematuria is strongly associated with a higher incidence of postdonation progressive kidney disease. Potential donors with persistent glomerular hematuria should be excluded, while those with isolated hematuria need to be evaluated with heightened caution.

1600-6143/asset/olbannerleft.gif?v=1&s=c46a3f174bfd9c6eb548cc809401524372c32e90)
1600-6143/asset/olbannerright.gif?v=1&s=9fc9790fa8ad5ef85aeaf408bf0d3d969d2fc012)
